J. A. Talano, C. A. Hillery, J. L. Gottschall, D. M. Baylerian, and J. P. Scott, Delayed Hemolytic Transfusion Reaction/Hyperhemolysis Syndrome in Children With Sickle Cell Disease, PEDIATRICS, vol.111, issue.6, pp.661-666, 2003.
DOI : 10.1542/peds.111.6.e661

E. Vichinsky, Current issues with blood transfusions in sickle cell disease, Seminars in Hematology, vol.38, issue.1, pp.14-22, 2001.
DOI : 10.1016/S0037-1963(01)90056-3

N. Elenga, V. Mialou, K. Kebaïli, C. Galambrun, Y. Bertrand et al., Severe Neurologic Complication After Delayed Hemolytic Transfusion Reaction in 2 Children With Sickle Cell Anemia, Journal of Pediatric Hematology/Oncology, vol.30, issue.12, pp.928-958, 2008.
DOI : 10.1097/MPH.0b013e31818c9172

M. De-montalembert, M. D. Dumont, C. Heilbronner, V. Brousse, O. Charrara et al., Delayed hemolytic transfusion reaction in children with sickle cell disease, Haematologica, vol.96, issue.6, pp.801-808, 2011.
DOI : 10.3324/haematol.2010.038307
URL : https://hal.archives-ouvertes.fr/inserm-00607864

F. Noizat-pirenne, T. Ournamille, and C. , Relevance of RH variants in transfusion of sickle cell patients, Transfusion Clinique et Biologique, vol.18, issue.5-6, pp.527-562, 2011.
DOI : 10.1016/j.tracli.2011.09.001

P. Chadebech, A. Habibi, R. Nzouakou, D. Bachir, N. Meunier-costes et al., Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death, Transfusion, vol.2007, issue.9, pp.1785-92, 2009.
DOI : 10.1111/j.1537-2995.2009.02199.x

B. Aygun, S. Padmanabhan, C. Paley, and V. Chandrasekaran, Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.Transfusion, 2002.

K. E. King, R. S. Shirey, M. W. Lankiewicz, J. Young-ramsaran, and P. M. Ness, Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells, Transfusion, vol.37, issue.4, pp.376-381, 1997.
DOI : 10.1046/j.1537-2995.1997.37497265337.x

W. J. Diamond, F. L. Brown, . Jr, P. Bitterman, H. G. Klein et al., Delayed Hemolytic Transfusion Reaction Presenting as Sickle-Cell Crisis, Annals of Internal Medicine, vol.93, issue.2, pp.231-235, 1980.
DOI : 10.7326/0003-4819-93-2-231

A. Fabron, . Jr, G. Moreira, . Jr, and J. O. Bordin, Delayed hemolytic transfusion reaction presenting as a painful crisis in a patient with sickle cell anemia, Sao Paulo Medical Journal, vol.117, issue.1, pp.38-47, 1999.
DOI : 10.1590/S1516-31801999000100007

K. Yazdanbakhsh, R. Ware, and F. Noizat-pirenne, Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management, Blood, vol.120, issue.3, pp.528-565, 2012.
DOI : 10.1182/blood-2011-11-327361
URL : https://hal.archives-ouvertes.fr/inserm-00696264

F. Noizat-pirenne, Relevance of blood groups in transfusion of sickle cell disease patients, Comptes Rendus Biologies, vol.336, issue.3, pp.152-160
DOI : 10.1016/j.crvi.2012.09.011

B. Natukunda, H. Schonewille, C. Ndugwa, and A. Brand, Red blood cell alloimmunization in sickle cell disease patients in Uganda, Transfusion, vol.48, issue.1, pp.20-25, 2010.
DOI : 10.1111/j.1537-2995.2009.02435.x

A. Olujohungbe, I. Hambleton, L. Stephens, B. Serjeant, and G. Serjeant, Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom, British Journal of Haematology, vol.81, issue.3, pp.661-665, 2001.
DOI : 10.1056/NEJM199507273330402

C. Rouillac, P. Gane, J. Cartron, L. Pennec, P. Y. Cartron et al., Molecular basis of the altered antigenic expression of RhD in weak D(Du) and RhC/e in RN phenotypes, Blood, vol.87, issue.11, pp.4853-4861, 1996.

M. E. Reid, J. R. Storry, L. Sausais, E. Tossas, M. Rios et al., DAK, a new low-incidence antigen in the Rh blood group system, Transfusion, vol.83, issue.10, pp.1394-1397, 2003.
DOI : 10.1046/j.1537-2995.1999.39111259.x

R. R. Anderson, S. D. Sosler, J. Kovach, and P. J. Dechristopher, in an Alloimmunized Patient With a Sickle Cell Syndrome, American Journal of Clinical Pathology, vol.108, issue.6, pp.658-661, 1997.
DOI : 10.1093/ajcp/108.6.658

L. Scheunemann and K. Ataga, Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease, The American Journal of the Medical Sciences, vol.339, issue.3, 2010.
DOI : 10.1097/MAJ.0b013e3181c70e14

F. Noizat-pirenne, Particularit??s immunoh??matologiques dans les populations africaines et antillaises. Implications transfusionnelles, Transfusion Clinique et Biologique, vol.10, issue.3, pp.185-191, 2003.
DOI : 10.1016/S1246-7820(03)00042-9

L. D. Petz, L. Calhoun, I. A. Shulman, C. Johnson, and R. M. Herron, The sickle cell hemolytic transfusion reaction syndrome, Transfusion, vol.37, issue.4, pp.382-392, 1997.
DOI : 10.1046/j.1537-2995.1997.37497265338.x

K. S. Lang, P. A. Lang, C. Bauer, C. Duranton, T. Wieder et al., Mechanisms of Suicidal Erythrocyte Death, Cellular Physiology and Biochemistry, vol.15, issue.5, pp.195-202, 2005.
DOI : 10.1159/000086406

K. E. King, R. S. Shirey, M. W. Lankiewicz, J. Young-ramsaran, and P. M. Ness, Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells, Transfusion, vol.37, issue.4, pp.376-81, 1997.
DOI : 10.1046/j.1537-2995.1997.37497265337.x

K. Darabi and S. Dzik, Hyperhemolysis syndrome in anemia of chronic disease, Transfusion, vol.74, issue.12, pp.1930-1933, 2005.
DOI : 10.1542/peds.111.6.e661

N. Win, H. Doughty, P. Telfer, B. J. Wild, and T. C. Pearson, Hyperhemolytic transfusion reaction in sickle cell disease, Transfusion, vol.73, issue.3, pp.323-331, 2001.
DOI : 10.1054/blre.1999.0121

O. S. Platt, Sickle cell anemia as an inflammatory disease, Journal of Clinical Investigation, vol.106, issue.3, pp.337-338, 2000.
DOI : 10.1172/JCI10726

N. Choileain, N. , and R. H. , Cell Response to Surgery, Archives of Surgery, vol.141, issue.11
DOI : 10.1001/archsurg.141.11.1132

J. C. Zimring and J. E. Hendrickson, The role of inflammation in alloimmunization to antigens on transfused red blood cells, Current Opinion in Hematology, vol.15, issue.6, pp.631-635, 2008.
DOI : 10.1097/MOH.0b013e328313695e

L. Alarif, O. Castro, M. Ofosu, G. Dunston, and R. B. Scott, HLA-B35 is associated with red cell alloimmunization in sickle cell disease, Clinical Immunology and Immunopathology, vol.38, issue.2, pp.178-183, 1986.
DOI : 10.1016/0090-1229(86)90136-4

E. G. Reisner, D. D. Kostyu, G. Phillip, C. Walker, and D. V. Dawson, Alloantibody responses in multiply transfused sickle cell patients, Tissue Antigens, vol.54, issue.4, pp.161-166, 1987.
DOI : 10.1111/j.1399-0039.1987.tb01615.x

C. Hoppe, W. Klitz, E. Vichinsky, and L. Styles, HLA type and risk of alloimmunization in sickle cell disease, American Journal of Hematology, vol.49, issue.7, pp.462-464, 2009.
DOI : 10.1002/ajh.21442

R. P. Hebbel, R. Osarogiagbon, and D. Kaul, The Endothelial Biology of Sickle Cell Disease: Inflammation and a Chronic Vasculopathy, Microcirculation, vol.11, issue.2, pp.129-151, 2004.
DOI : 10.1080/mic.11.2.129.151

J. O. Cullis, N. Win, J. M. Dudley, and T. Kaye, Post-Transfusion Hyperhaemolysis in a Patient with Sickle Cell Disease: Use of Steroids and Intravenous Immunoglobulin to Prevent Further Red Cell Destruction, Vox Sanguinis, vol.67, issue.suppl, pp.355-357, 1995.
DOI : 10.1111/j.1423-0410.1995.tb00373.x

N. Win, Y. Needs, M. Chen, P. E. Okpala, and I. , Use of Intravenous Immunoglobulin and Intravenous Methylprednisolone in Hyperhaemolysis Syndrome in Sickle Cell Disease, Hematology, vol.73, issue.5-6, pp.433-436, 2004.
DOI : 10.1212/01.WNL.0000068335.01620.9D

N. Win, H. New, E. Lee, and J. De-la-fuente, Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review, Transfusion, vol.73, issue.6, pp.1231-1238, 2008.
DOI : 10.1002/1096-8652(200102)66:2<151::AID-AJH1035>3.3.CO;2-H

W. B. Reeves and S. K. Ballas, Delayed hemolytic transfusion reaction in sickle cell anemia, Transfusion, vol.20, issue.4, p.477, 1980.
DOI : 10.1046/j.1537-2995.1980.20480260288.x

M. A. Reyes and O. C. Illoh, Hyperhemolytic transfusion reaction attributable to anti-Fy3 in a patient with sickle cell disease, Immunohematology, vol.24, issue.2, pp.45-51, 2008.

D. Seeyave, N. Desai, S. Miller, S. P. Rao, and S. Piecuch, Fatal delayed transfusion reaction in a sickle cell anemia patient with Serratia marcescens sepsis, J Natl Med Assoc, vol.98, issue.10, pp.1697-1706, 2006.

M. Kalyanaraman, S. M. Heidemann, A. P. Sarnaik, K. L. Meert, and S. A. Sarnaik, Anti-s Antibody-Associated Delayed Hemolytic Transfusion Reaction in Patients With Sickle Cell Anemia, Journal of Pediatric Hematology/Oncology, vol.21, issue.1, pp.70-73, 1999.
DOI : 10.1097/00043426-199901000-00016

A. Strupp, K. Cash, and J. Uehlinger, Difficulties in identifying antibodies in the Dombrock blood group system in multiply alloimmunized patients.Transfusion, pp.11-12, 1998.

P. J. Larson, M. B. Lukas, D. F. Friedman, and C. S. Manno, Delayed hemolytic transfusion reaction due to anti-Go(a), an antibody against the low-prevalence Gonzales antigen, Am J Hematol, 1996.

C. D. Hillyer, J. M. Hall, K. O. Berkman, and E. M. , Case report and review: alloimmunization, delayed hemolytic transfusion reaction, and clinically significant anti-Yt (a) in a patient with Beta-thalassemia/sickle cell anemia, Immunohematology, vol.7, issue.4, pp.102-108, 1991.

D. T. Bowen, A. Devenish, J. Dalton, and P. E. Hewitt, and Anti-Fy5, Vox Sanguinis, vol.52, issue.1, pp.35-41, 1988.
DOI : 10.1111/j.1423-0410.1988.tb04685.x

S. K. Ballas, C. Dignam, M. Harris, and M. J. Marcolina, A clinically significant anti-N in a patient whose red cells were negative for N and U antigens. Transfusion, pp.377-80, 1985.

S. A. Chan-shu, The second example of anti-Duffy5. Transfusion, pp.358-60, 1980.

K. Ohene-frempong, Indications for red cell transfusion in sickle cell disease, Seminars in Hematology, vol.38, issue.1 1, pp.5-13, 2001.
DOI : 10.1016/S0037-1963(01)90055-1

S. E. Hannema, A. Brand, A. Van-meurs, and F. J. Smiers, Delayed hemolytic transfusion reaction with hyperhemolysis after first red blood cell transfusion in child with ??-thalassemia: challenges in treatment, Transfusion, vol.11, issue.2, pp.429-461, 2010.
DOI : 10.1111/j.1537-2995.2009.02399.x

F. Noizat-pirenne, D. Bachir, P. Chadebech, M. Michel, A. Plonquet et al., Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease, Haematologica, vol.92, issue.12, pp.132-137, 2007.
DOI : 10.3324/haematol.12074

N. Win, T. Yeghen, M. Needs, F. E. Chen, and I. Okpala, Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease. Hematology, pp.5-6433, 2004.

T. C. Griffin, D. Mcintire, and G. R. Buchanan, High-Dose Intravenous Methylprednisolone Therapy for Pain in Children and Adolescents with Sickle Cell Disease, New England Journal of Medicine, vol.330, issue.11, pp.733-740, 1994.
DOI : 10.1056/NEJM199403173301101

J. C. Bernini, Z. R. Rogers, E. S. Sandler, J. S. Reisch, C. T. Quinn et al., Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease, Blood, vol.92, issue.9, pp.3082-3091, 1998.

K. Nistala and K. J. Murray, Co-existent sickle cell disease and juvenile rheumatoid arthritis. T wo cases with delayed diagnosis and severe destructive arthropathy, J Rheumatol, vol.28, issue.9, pp.2125-2133, 2001.

D. D. Gladman and C. Bombardier, Sickle cell crisis following intraarticular steroid therapy for rheumatoid arthritis, Arthritis & Rheumatism, vol.9, issue.9, pp.1065-1073, 1987.
DOI : 10.1002/art.1780300916

P. Lykavieris, J. J. Benichou, M. Benkerrou, J. P. Feriot, O. Bernard et al., Autoimmune Liver Disease in Three Children with Sickle Cell Disease, Journal of Pediatric Gastroenterology and Nutrition, vol.42, issue.1, pp.104-112, 2006.
DOI : 10.1097/01.MPG.0000162480.81900.AF

S. Couillard, M. Benkerrou, R. Girot, V. Brousse, A. Ferster et al., Steroid treatment in children with sickle-cell disease, Haematologica, vol.92, issue.3, pp.425-431, 2007.
DOI : 10.3324/haematol.10800

M. S. Isakoff, J. A. Lillo, and J. N. Hagstrom, A Single-Institution Experience With Treatment of Severe Acute Chest Syndrome: Lack of Rebound Pain With Dexamethasone Plus Transfusion Therapy, Journal of Pediatric Hematology/Oncology, vol.30, issue.4, pp.322-327, 2008.
DOI : 10.1097/MPH.0b013e3181647bb2

V. Taylor, R. F. Machado, T. Heller, O. Castro, and M. T. Gladwin, Combination Erythropoietin-Hy droxyurea Therapy in Sickle Cell Disease: NIH experience and literature review, Haematologica, vol.91, issue.8, pp.1076-1083, 2006.